Nanoinformatics and nanotechnology in anti-inflammatory therapy: A review

AK Mishra, L Rani, R Singh, HK Dewangan… - Journal of Drug Delivery …, 2024 - Elsevier
A necessary immune response that promotes survival and preserves tissue homeostasis,
inflammation is a frequent characteristic of many disorders. In other circumstances, however …

Will we ever cure nasal polyps?

NH Ta - The Annals of The Royal College of Surgeons of …, 2019 - publishing.rcseng.ac.uk
BACKGROUND Nasal polyposis is a benign hyperplastic growth of nasal mucosa. There is
a paucity of evidence on the prevalence and incidence of nasal polyposis. Although nasal …

The socioeconomic cost of chronic rhinosinusitis study

NW Wahid, R Smith, A Clark, M Salam, C Philpott - Rhinology, 2020 - ueaeprints.uea.ac.uk
INTRODUCTION: Chronic rhinosinusitis (CRS) is highly prevalent, affecting 11% of the
population. Studies evaluating the socio-economic impact of CRS are mostly limited to the …

Chronic rhinosinusitis: a qualitative study of patient views and experiences of current management in primary and secondary care

J Vennik, C Eyles, M Thomas, C Hopkins, P Little… - BMJ open, 2019 - bmjopen.bmj.com
Objectives To explore patient views and perspectives of current management of chronic
rhinosinusitis (CRS) in primary and secondary care. Design Semistructured qualitative …

Factors impacting revision surgery in patients with chronic rhinosinusitis with nasal polyposis

CA Loftus, ZM Soler, VM Desiato… - … Forum of Allergy & …, 2020 - Wiley Online Library
Background Surgical treatment of chronic rhinosinusitis with nasal polyposis (CRSwNP) has
evolved over the last decade as rhinologists have increasingly used topical steroid therapies …

Management strategies for chronic rhinosinusitis: a qualitative study of GP and ENT specialist views of current practice in the UK

J Vennik, C Eyles, M Thomas, C Hopkins, P Little… - BMJ open, 2018 - bmjopen.bmj.com
Objectives To explore general practitioner (GP) and ears, nose and throat (ENT) specialist
perspectives of current treatment strategies for chronic rhinosinusitis (CRS) and care …

Socioeconomic, comorbidity, lifestyle, and quality of life comparisons between chronic rhinosinusitis phenotypes

C Philpott, NH Ta, C Hopkins, J Ray… - The …, 2021 - Wiley Online Library
Background Chronic rhinosinusitis (CRS) is a heterogeneous group of inflammatory
sinonasal disorders with key defining symptoms, but traditionally separated into phenotypes …

Mometasone furoate sinus implant–a new targeted approach to treating recurrent nasal polyp disease

J Shen, K Welch, R Kern - Expert review of clinical pharmacology, 2018 - Taylor & Francis
Introduction: Chronic rhinosinusitis (CRS) is a broad heterogeneous inflammatory disorder
of the nose and paranasal sinuses, resulting from the dysfunctional interplay between host …

Dysregulated maresin concentrations in plasma and nasal secretions from patients with chronic rhinosinusitis

I Beegun, DS Koenis, G Alusi, J Dalli - Frontiers in Immunology, 2021 - frontiersin.org
The mechanisms that lead to disease onset and propagation in patients with chronic
rhinosinusitis (CRS) are not fully elucidated. Maresins (MaR) are a family of essential fatty …

Medication use in patients with chronic rhinosinusitis in Germany-a large retrospective patient-based study.

JJH Park, DU Seidel, C Bachert, S Dazert, K Kostev - Rhinology, 2019 - europepmc.org
Background The aim of the present study was to provide an insight into medical treatment
practices among patients with chronic rhinosinusitis (CRS) in Germany. An investigation of …